13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 103 holding rows worth $2,791,662,000.
- Accession
- 0001567619-18-006280
- Filer
- CIK 1009258
- Filed
- 2018-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 103 entries on the cover page, a total value of $2,791,662,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,791,662,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON PHARMA PLC | G4617B105 | SHS | 6,609,894 | $129,422,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 5,227,035 | $119,490,000 | thousands by filing date | |
| HORIZON PHARMA INVT LTD | 44052TAB7 | NOTE 2.500% 3/1 | 99,100,000 | $99,537,000 | thousands by filing date | principal |
| NEVRO CORP | 64157FAA1 | BOND | 100,000,000 | $99,400,000 | thousands by filing date | principal |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 1,540,448 | $94,815,000 | thousands by filing date | |
| DEXCOM INC | 252131AF4 | NOTE 0.750% 5/1 | 55,000,000 | $84,160,000 | thousands by filing date | principal |
| MYLAN NV | N59465109 | SHS EURO | 1,842,111 | $67,421,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 2,455,586 | $65,392,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 2,900,000 | $65,134,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 647,466 | $64,598,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,117,651 | $63,963,000 | thousands by filing date | |
| ENDOCYTE INC | 29269A102 | COM | 3,514,084 | $62,410,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 2,147,950 | $61,754,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 917,000 | $59,788,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 6,910,789 | $52,729,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,424,571 | $50,145,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 656,500 | $49,789,000 | thousands by filing date | |
| KEMPHARM INC | 488445AB3 | NOTE 5.500 2/0 | 75,000,000 | $48,281,000 | thousands by filing date | principal |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 296,000 | $47,807,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 4,707,912 | $46,279,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | 98236JAB4 | NOTE 2.250%11/1 | 31,500,000 | $45,572,000 | thousands by filing date | principal |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 3,093,416 | $44,916,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 566,800 | $44,618,000 | thousands by filing date | call |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 2,498,666 | $43,927,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 525,000 | $40,982,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 840,911 | $39,607,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 569,356 | $36,951,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,158,841 | $36,874,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 36,000,000 | $36,248,000 | thousands by filing date | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 245,000 | $35,471,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 1,227,061 | $34,677,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 262,000 | $33,494,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,590,000 | $33,120,000 | thousands by filing date | |
| K2M GROUP HLDGS INC | 48273JAB3 | NOTE 4.125% 8/1 | 20,000,000 | $30,080,000 | thousands by filing date | principal |
| NEVRO CORP | 64157F103 | COM | 525,040 | $29,927,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 260,064 | $29,239,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 1,526,000 | $28,078,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 1,061,956 | $27,080,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 348,200 | $26,853,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 95,000 | $26,035,000 | thousands by filing date | |
| DFB HEALTHCARE ACQUISTION CO | 23291E208 | UNIT 01/30/2023 | 2,500,000 | $25,500,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 294,000 | $24,037,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 1,617,730 | $22,891,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 320,000 | $22,675,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,233,734 | $20,813,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 275,000 | $20,763,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 493,901 | $19,554,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 1,365,143 | $19,399,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,173,617 | $19,118,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 1,779,094 | $18,858,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 1,087,359 | $17,648,000 | thousands by filing date | |
| DIPLOMAT PHARMACY INC | 25456K101 | COM | 853,687 | $16,570,000 | thousands by filing date | |
| MORPHOSYS AG | 617760202 | ADR | 600,000 | $16,020,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 121,000 | $15,908,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 3,491,922 | $15,190,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 1,268,945 | $15,113,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 553,000 | $15,086,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 287,000 | $15,007,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,343,181 | $14,882,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 650,000 | $14,372,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 593,769 | $14,179,000 | thousands by filing date | |
| AMERISOURCEBERGEN COR | 000307108 | COMMON | 1,853,998 | $14,146,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 729,948 | $13,504,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 283,115 | $12,129,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 2,722,241 | $11,951,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 688,062 | $11,511,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 365,689 | $10,667,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960WAA2 | BOND | 9,567,000 | $10,401,000 | thousands by filing date | principal |
| NIGHTSTAR THERAPEUTICS PLC | 65413A101 | ADR | 499,747 | $10,210,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 225,000 | $10,123,000 | thousands by filing date | |
| MELINTA THERAPEUTICS INC | 58549G100 | COM | 2,311,858 | $9,132,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 239,000 | $8,974,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 61,435 | $8,970,000 | thousands by filing date | |
| NUVASIVE INC | 670704AG0 | NOTE 2.250% 3/1 | 7,000,000 | $8,865,000 | thousands by filing date | principal |
| LIVANOVA PLC | G5509L101 | SHS | 71,500 | $8,864,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 241,430 | $8,786,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 475,000 | $8,089,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 460,000 | $8,013,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 189,000 | $7,953,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 250,000 | $7,668,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 382,700 | $6,923,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 280,000 | $6,894,000 | thousands by filing date | |
| NUVECTRA CORP | 67075N108 | COM | 278,890 | $6,130,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 6,052,935 | $5,932,000 | thousands by filing date | |
| PFENEX INC | 717071104 | COM | 1,069,514 | $5,465,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 29,249 | $5,052,000 | thousands by filing date | |
| ADDUS HOMECARE CORP | 006739106 | COM | 65,590 | $4,601,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 635,843 | $4,279,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 420,409 | $4,196,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 120,000 | $3,955,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 612,867 | $3,879,000 | thousands by filing date | |
| IGI LABORATORIES INC | 449575AB5 | NOTE 3.75012/1 | 3,733,000 | $3,555,000 | thousands by filing date | principal |
| BIOSCRIP INC | 09069N108 | COM | 1,023,379 | $3,172,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 708,873 | $2,800,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 250,000 | $2,790,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,224,899 | $2,389,000 | thousands by filing date | |
| RA MED SYS INC | 74933X104 | COM | 128,600 | $2,341,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 117,647 | $2,226,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 58,247 | $2,134,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 234,745 | $1,345,000 | thousands by filing date | |
| EYENOVIA INC | 30234E104 | COM | 300,000 | $1,206,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HLDGS IN | 71426V306 | COM NEW | 658,826 | $635,000 | thousands by filing date | |
| Ocugen | 43358V109 | Common | 296,099 | $161,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-18-006280 | this filing | 2018-11-14 | acceptance time not in the bulk data set |